Throughout the year 2019 and every year since my MCL (mantel cell lymphoma) diagnosis (DX) in 2006, an ever-growing network of sites, blogs, and social media outlets have come to my attention. Friends, many convene multi-stakeholder working groups, hosts scientific conferences and roundtables, and conducts original research to promote innovative and meaningful improvements in drug development and patient care.
This work is built from expert working groups of thought leaders representing federal officials, medical experts, regulators, drug sponsors, diagnostic companies, academic researchers, and patient advocates. These publications help inform policy makers and other key stakeholders to catalyze the development of innovative strategies and regulatory policies for new drug development. See BLOG